ETX.L - e-Therapeutics plc

LSE - LSE Delayed Price. Currency in GBp
Currency in GBp

Valuation Measures

Market Cap (intraday) 520.15M
Enterprise Value 312.5M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)234.37
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.20

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jan 31, 2018
Most Recent Quarter (mrq)Jul 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.10%
Return on Equity (ttm)-42.14%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -5.69M
Net Income Avi to Common (ttm)-4.57M
Diluted EPS (ttm)-1.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.64M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.59
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-4.82M
Levered Free Cash Flow (ttm)-3.82M

Trading Information

Stock Price History

Beta (3Y Monthly) -1.15
52-Week Change 3-29.41%
S&P500 52-Week Change 39.71%
52 Week High 310.65
52 Week Low 35.80
50-Day Moving Average 37.62
200-Day Moving Average 37.49

Share Statistics

Avg Vol (3 month) 332.62k
Avg Vol (10 day) 357.12k
Shares Outstanding 5268.6M
Float 199.79M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A